Dr. Lisa Teot, MD

• Cytopathology

• Anatomic & Clinical Pathology

• Tumor Pathology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• George Washington University Medical Center

  Residency Hospital, 1991

• George Washington University Medical Center|north Carolina Baptist Hospital, Bowman Gray School Of Medicine

  Residency Hospital, 1991

• North Carolina Baptist Hospital, Bowman Gray School Of Medicine

  Residency Hospital, 1991

• George Washington University Medical Center

  Internship Hospital, 1988

• George Washington University

  Medical School, 1986

• Williams College

  Undergraduate School, 1982

• Clinical and mutational spectrum of highly differentiated, PAX:FOXO1 fusion-negative rhabdomyosarcoma - a report from the Children's Oncology Group, 2018-02-20

• Dense Pattern of Embryonal Rhabdomyosarcoma, a Lesion Easily Confused With Alveolar Rhabdomyosarcoma A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group, 2015-10-24

• Assessment of Extent of Surgical Resection of Primary High-Grade Osteosarcoma by Treating Institutions: A Report From the Children's Oncology Group, 2016-01-18

• Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee, 2016-04-29

• Metabolic response as assessed by18F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee, 2020-12-19

• Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma A Report From the Children's Oncology Group, 2021-12-01

• An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials, 2022-02-07

• Histology, Fusion Status and Outcome in Alveolar Rhabdomyosarcoma with Low-Risk Clinical Features: A Report from the Children's Oncology Group, 2016-01-12

• Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group, 2017-05-18

• Anaplastic Rhabdomyosarcoma inTP53Germline Mutation Carriers, 2013-12-30

• The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology Group, 2020-12-07

• The Addition of Cixutumumab or Temozolomide to Intensive Multiagent Chemotherapy Is Feasible but Does Not Improve Outcome for Patients with Metastatic Rhabdomyosarcoma: A Report from the Children's Oncology Group, 2018-10-23

• Mutations in Hedgehog pathway genes in fetal rhabdomyomas, 2013-12-06

• Myogenin, AP2ß, NOS-1 and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma, 2014-04-24